Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      FDA Approves First Oral Treatment for Postpartum Depression
      Biotech

      FDA Approves First Oral Treatment for Postpartum Depression

      August 5, 2023
      PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
      Biotech

      PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)

      August 5, 2023
      Global Small Molecule CDMO Industry Research Report 2023
      Biotech

      Global Small Molecule CDMO Industry Research Report 2023

      August 5, 2023
      FDA Roundup: August 4, 2023
      Biotech

      FDA Roundup: August 4, 2023

      August 5, 2023
      Agricultural Biologicals Market To Reach USD 13500 million by 2029, witnessing a CAGR of 7.1% | Valuates Reports
      Biotech

      Agricultural Biologicals Market To Reach USD 13500 million by 2029, witnessing a CAGR of 7.1% | Valuates Reports

      August 4, 2023
      AI+ Media Development Platform AlfaOPA™ Officially Launched
      Biotech

      AI+ Media Development Platform AlfaOPA™ Officially Launched

      August 4, 2023
      Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
      Biotech

      Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update

      August 4, 2023
      Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th
      Biotech

      Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th

      August 4, 2023
      Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer
      Biotech

      Complement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical Officer

      August 3, 2023
      Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
      Biotech

      Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors

      August 3, 2023
      « 1 … 99 100 101 102 103 … 126 »

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025